Alternatives to Lexeo Therapeutics

A biotechnology company developing genetic therapies for rare disorders.

Biotechnology company developing gene therapies and regenerative medicine for heart disease.

Clinical-stage biotechnology company developing Antibody Oligonucleotide Conjugates (AOCs) for serious diseases.

Gene therapy company developing treatments for rare inherited diseases.

Gene therapy company developing transformative treatments for severe genetic diseases.

Ridge Bio is developing a novel gene therapy platform for treating rare genetic diseases.

Develops advanced gene editing and cell therapy solutions for rare genetic diseases.

Leveraging the adaptive immune system to diagnose and treat disease.

A global oncology company developing and commercializing innovative cancer treatments.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

Biopharmaceutical company focused on developing and commercializing innovative treatments for rare neurological disorders.

Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.

Clinical-stage biopharmaceutical company developing gene therapies for rare genetic diseases.

Biopharmaceutical company developing novel therapies for rare and ultra-rare genetic diseases.

Clinical-stage biotech company developing AAV gene therapies for rare and retinal diseases.

AI-powered platform for personalized cell therapy development and manufacturing.

A precision biotechnology company developing a blood-based platform for early cancer detection and treatment.

Biopharmaceutical company developing antibody-based therapeutics for cancer and autoimmune diseases.

Develops novel protein engineering and directed evolution technologies for therapeutic discovery.

Developing advanced cell culture media and bioprocessing solutions for cell and gene therapy.